The Aceto Corp. headquarters in Port Washington.

The Aceto Corp. headquarters in Port Washington. Credit: Barry Sloan

Aceto Corp. said Monday it plans to begin selling a medicine to treat migraines.

The Port Washington-based manufacturer of drugs and chemicals said it would launch zolmitriptan tablets, a generic version of Zomig from IPR Pharamaceuticals Inc.

The drug information provider IMS Health estimated U.S. sales of zolmitriptan totaled $49 million last year.

The generic drug will be sold by Aceto’s Rising Pharmaceuticals subsidiary, which is based in New Jersey.

Aceto made the announcement after the stock market opening. The company’s stock fell 13 cents to $23.46 on the Nasdaq Stock Market Monday.

Working Moms: Finding your 'village' ... Hospitals with high safety ratings ... Look ahead at the weather Credit: Newsday

Lower tax levy, leaner town budget after outrage ... 8 of the highest-paid educators in state work here ... Oheka sale finalized ... Working Moms: Finding your 'village'

Working Moms: Finding your 'village' ... Hospitals with high safety ratings ... Look ahead at the weather Credit: Newsday

Lower tax levy, leaner town budget after outrage ... 8 of the highest-paid educators in state work here ... Oheka sale finalized ... Working Moms: Finding your 'village'

Subscribe

Unlimited Digital AccessOnly 25¢for 6 months

SUBSCRIBESALE ENDS SOON | CANCEL ANYTIME